REYKJAVIK, Aug. 10, 2006 (PRIMEZONE) -- Actavis Group (“ACT”) (ICEX:ACT), the international generic pharmaceuticals company, announces its results for the second quarter ended 30 June 2006. Sindan, the Romanian oncology business acquired at the end of March, is fully integrated into the Group’s accounts from the start of the second quarter.
